As of January 2026 Prelude Therapeutics has a market cap of A$0.27 Billion. This makes Prelude Therapeutics the world's 8622th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Jan 1st, 2026 the market cap of Prelude Therapeutics was reported to be: